These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


432 related items for PubMed ID: 11042379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction.
    Hermes-Lima M, Santos NC, Yan J, Andrews M, Schulman HM, Ponka P.
    Biochim Biophys Acta; 1999 Feb 02; 1426(3):475-82. PubMed ID: 10076064
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against *OH-mediated strand breaks.
    Hermes-Lima M, Nagy E, Ponka P, Schulman HM.
    Free Radic Biol Med; 1998 Nov 15; 25(8):875-80. PubMed ID: 9840731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
    Santos NC, Castilho RF, Meinicke AR, Hermes-Lima M.
    Eur J Pharmacol; 2001 Sep 28; 428(1):37-44. PubMed ID: 11779035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR, Tran EH, Ponka P.
    Blood; 1995 Dec 01; 86(11):4295-306. PubMed ID: 7492790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
    Buss JL, Neuzil J, Ponka P.
    Arch Biochem Biophys; 2004 Jan 01; 421(1):1-9. PubMed ID: 14678779
    [Abstract] [Full Text] [Related]

  • 13. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR, Milnes K.
    Blood; 1997 Apr 15; 89(8):3025-38. PubMed ID: 9108424
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
    Thomas C, Vile GF, Winterbourn CC.
    Biochem Pharmacol; 1993 May 25; 45(10):1967-72. PubMed ID: 8390256
    [Abstract] [Full Text] [Related]

  • 17. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E, Vitolo ML, Webb J.
    Biochem Pharmacol; 1985 Sep 01; 34(17):3011-7. PubMed ID: 4038321
    [Abstract] [Full Text] [Related]

  • 18. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions.
    Lopes GK, Schulman HM, Hermes-Lima M.
    Biochim Biophys Acta; 1999 Oct 18; 1472(1-2):142-52. PubMed ID: 10572935
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A study of the mechanism of action of pyridoxal isonicotinoyl hydrazone at the cellular level using reticulocytes loaded with non-heme 59Fe.
    Huang AR, Ponka P.
    Biochim Biophys Acta; 1983 Jun 09; 757(3):306-15. PubMed ID: 6849979
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.